United States Virus Like Particles Market Report 2019

Table of Contents

United States Virus Like Particles Market Report2019
1 Virus Like Particles Overview
1.1 Product Overview and Scope of Virus Like Particles
1.2 Classification of Virus Like Particles by Product Category
1.2.1 United States Virus Like Particles Market Size (Sales Volume) Comparison by Type (2014-2024)
1.2.2 United States Virus Like Particles Market Size (Sales Volume) Market Share by Type (Product Category) in 2018
1.2.3 Adeno-Associated Virus
1.2.4 HIV
1.2.5 Hepatitis B Virus
1.2.6 Hepatitis C Virus
1.2.7 Other
1.3 United States Virus Like Particles Market by Application/End Users
1.3.1 United States Virus Like Particles Market Size (Consumption) and Market Share Comparison by Application (2014-2024)
1.3.2 Vaccines
1.3.3 Mycoviruses
1.3.4 Virus Research
1.3.5 Therapeutic and Imaging Agents
1.3.6 Other
1.4 United States Virus Like Particles Market by Region
1.4.1 United States Virus Like Particles Market Size (Value) Comparison by Region (2014-2024)
1.4.2 The West Virus Like Particles Status and Prospect (2014-2024)
1.4.3 Southwest Virus Like Particles Status and Prospect (2014-2024)
1.4.4 The Middle Atlantic Virus Like Particles Status and Prospect (2014-2024)
1.4.5 New England Virus Like Particles Status and Prospect (2014-2024)
1.4.6 The South Virus Like Particles Status and Prospect (2014-2024)
1.4.7 The Midwest Virus Like Particles Status and Prospect (2014-2024)
1.5 United States Market Size (Value and Volume) of Virus Like Particles (2014-2024)
1.5.1 United States Virus Like Particles Sales and Growth Rate (2014-2024)
1.5.2 United States Virus Like Particles Revenue and Growth Rate (2014-2024)

2 United States Virus Like Particles Market Competition by Players/Suppliers
2.1 United States Virus Like Particles Sales and Market Share of Key Players/Suppliers (2014-2019)
2.2 United States Virus Like Particles Revenue and Share by Players/Suppliers (2014-2019)
2.3 United States Virus Like Particles Average Price by Players/Suppliers (2014-2019)
2.4 United States Virus Like Particles Market Competitive Situation and Trends
2.4.1 United States Virus Like Particles Market Concentration Rate
2.4.2 United States Virus Like Particles Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Virus Like Particles Manufacturing Base Distribution, Sales Area, Product Type

3 United States Virus Like Particles Sales (Volume) and Revenue (Value) by Region (2014-2019)
3.1 United States Virus Like Particles Sales and Market Share by Region (2014-2019)
3.2 United States Virus Like Particles Revenue and Market Share by Region (2014-2019)
3.3 United States Virus Like Particles Price by Region (2014-2019)

4 United States Virus Like Particles Sales (Volume) and Revenue (Value) by Type (Product Category) (2014-2019)
4.1 United States Virus Like Particles Sales and Market Share by Type (Product Category) (2014-2019)
4.2 United States Virus Like Particles Revenue and Market Share by Type (2014-2019)
4.3 United States Virus Like Particles Price by Type (2014-2019)
4.4 United States Virus Like Particles Sales Growth Rate by Type (2014-2019)

5 United States Virus Like Particles Sales (Volume) by Application (2014-2019)
5.1 United States Virus Like Particles Sales and Market Share by Application (2014-2019)
5.2 United States Virus Like Particles Sales Growth Rate by Application (2014-2019)
5.3 Market Drivers and Opportunities

6 United States Virus Like Particles Players/Suppliers Profiles and Sales Data
6.1 GlaxoSmithKline
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Virus Like Particles Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 GlaxoSmithKline Virus Like Particles Sales, Revenue, Price and Gross Margin (2014-2019)
6.1.4 Main Business/Business Overview
6.2 Merck
6.2.2 Virus Like Particles Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Merck Virus Like Particles Sales, Revenue, Price and Gross Margin (2014-2019)
6.2.4 Main Business/Business Overview
6.3 Novavax
6.3.2 Virus Like Particles Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Novavax Virus Like Particles Sales, Revenue, Price and Gross Margin (2014-2019)
6.3.4 Main Business/Business Overview
6.4 Takeda
6.4.2 Virus Like Particles Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Takeda Virus Like Particles Sales, Revenue, Price and Gross Margin (2014-2019)
6.4.4 Main Business/Business Overview
6.5 Medicago
6.5.2 Virus Like Particles Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Medicago Virus Like Particles Sales, Revenue, Price and Gross Margin (2014-2019)
6.5.4 Main Business/Business Overview
6.6 MedImmune
6.6.2 Virus Like Particles Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 MedImmune Virus Like Particles Sales, Revenue, Price and Gross Margin (2014-2019)
6.6.4 Main Business/Business Overview
6.7 TechnoVax
6.7.2 Virus Like Particles Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 TechnoVax Virus Like Particles Sales, Revenue, Price and Gross Margin (2014-2019)
6.7.4 Main Business/Business Overview
6.8 Agilvax
6.8.2 Virus Like Particles Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Agilvax Virus Like Particles Sales, Revenue, Price and Gross Margin (2014-2019)
6.8.4 Main Business/Business Overview
6.9 Allergy Therapeutics
6.9.2 Virus Like Particles Product Category, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Allergy Therapeutics Virus Like Particles Sales, Revenue, Price and Gross Margin (2014-2019)
6.9.4 Main Business/Business Overview
6.10 Serum Institute of India
6.10.2 Virus Like Particles Product Category, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Serum Institute of India Virus Like Particles Sales, Revenue, Price and Gross Margin (2014-2019)
6.10.4 Main Business/Business Overview
6.11 GeoVax Labs
6.12 Cytos Biotechnology
6.13 ANGANY Genetics
6.14 CPL Biologicals
6.15 Xiamen Innovax Biotech

7 Virus Like Particles Manufacturing Cost Analysis
7.1 Virus Like Particles Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Virus Like Particles

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Virus Like Particles Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Virus Like Particles Major Manufacturers in 2018
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 United States Virus Like Particles Market Size (Value and Volume) Forecast (2019-2024)
11.1 United States Virus Like Particles Sales Volume, Revenue Forecast (2019-2024)
11.2 United States Virus Like Particles Sales Volume Forecast by Type (2019-2024)
11.3 United States Virus Like Particles Sales Volume Forecast by Application (2019-2024)
11.4 United States Virus Like Particles Sales Volume Forecast by Region (2019-2024)

12 Research Findings and Conclusion

13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer



List of Tables and Figures

Figure Product Picture of Virus Like Particles
Figure United States Virus Like Particles Market Size (K Pcs) by Type (2014-2024)
Figure United States Virus Like Particles Sales Volume Market Share by Type (Product Category) in 2018
Figure Adeno-Associated Virus Product Picture
Figure HIV Product Picture
Figure Hepatitis B Virus Product Picture
Figure Hepatitis C Virus Product Picture
Figure Other Product Picture
Figure United States Virus Like Particles Market Size (K Pcs) by Application (2014-2024)
Figure United States Sales Market Share of Virus Like Particles by Application in 2018
Figure Vaccines Examples
Table Key Downstream Customer in Vaccines
Figure Mycoviruses Examples
Table Key Downstream Customer in Mycoviruses
Figure Virus Research Examples
Table Key Downstream Customer in Virus Research
Figure Therapeutic and Imaging Agents Examples
Table Key Downstream Customer in Therapeutic and Imaging Agents
Figure Other Examples
Table Key Downstream Customer in Other
Figure United States Virus Like Particles Market Size (Million USD) by Region (2014-2024)
Figure The West Virus Like Particles Revenue (Million USD) and Growth Rate (2014-2024)
Figure Southwest Virus Like Particles Revenue (Million USD) and Growth Rate (2014-2024)
Figure The Middle Atlantic Virus Like Particles Revenue (Million USD) and Growth Rate (2014-2024)
Figure New England Virus Like Particles Revenue (Million USD) and Growth Rate (2014-2024)
Figure The South of US Virus Like Particles Revenue (Million USD) and Growth Rate (2014-2024)
Figure The Midwest Virus Like Particles Revenue (Million USD) and Growth Rate (2014-2024)
Figure United States Virus Like Particles Sales (K Pcs) and Growth Rate (2014-2024)
Figure United States Virus Like Particles Revenue (Million USD) and Growth Rate (2014-2024)
Figure United States Virus Like Particles Market Major Players Product Sales Volume (K Pcs) (2014-2019)
Table United States Virus Like Particles Sales (K Pcs) of Key Players/Suppliers (2014-2019)
Table United States Virus Like Particles Sales Share by Players/Suppliers (2014-2019)
Figure 2018 United States Virus Like Particles Sales Share by Players/Suppliers
Figure 2019 United States Virus Like Particles Sales Share by Players/Suppliers
Figure United States Virus Like Particles Market Major Players Product Revenue (Million USD) (2014-2019)
Table United States Virus Like Particles Revenue (Million USD) by Players/Suppliers (2014-2019)
Table United States Virus Like Particles Revenue Share by Players/Suppliers (2014-2019)
Figure 2018 United States Virus Like Particles Revenue Share by Players/Suppliers
Figure 2019 United States Virus Like Particles Revenue Share by Players/Suppliers
Table United States Market Virus Like Particles Average Price (USD/Pcs) of Key Players/Suppliers (2014-2019)
Figure United States Market Virus Like Particles Average Price (USD/Pcs) of Key Players/Suppliers in 2018
Figure United States Virus Like Particles Market Share of Top 3 Players/Suppliers
Figure United States Virus Like Particles Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Virus Like Particles Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Virus Like Particles Product Category
Table United States Virus Like Particles Sales (K Pcs) by Region (2014-2019)
Table United States Virus Like Particles Sales Share by Region (2014-2019)
Figure United States Virus Like Particles Sales Share by Region (2014-2019)
Figure United States Virus Like Particles Sales Market Share by Region in 2018
Table United States Virus Like Particles Revenue (Million USD) and Market Share by Region (2014-2019)
Table United States Virus Like Particles Revenue Share by Region (2014-2019)
Figure United States Virus Like Particles Revenue Market Share by Region (2014-2019)
Figure United States Virus Like Particles Revenue Market Share by Region in 2018
Table United States Virus Like Particles Price (USD/Pcs) by Region (2014-2019)
Table United States Virus Like Particles Sales (K Pcs) by Type (2014-2019)
Table United States Virus Like Particles Sales Share by Type (2014-2019)
Figure United States Virus Like Particles Sales Share by Type (2014-2019)
Figure United States Virus Like Particles Sales Market Share by Type in 2018
Table United States Virus Like Particles Revenue (Million USD) and Market Share by Type (2014-2019)
Table United States Virus Like Particles Revenue Share by Type (2014-2019)
Figure Revenue Market Share of Virus Like Particles by Type (2014-2019)
Figure Revenue Market Share of Virus Like Particles by Type in 2018
Table United States Virus Like Particles Price (USD/Pcs) by Types (2014-2019)
Figure United States Virus Like Particles Sales Growth Rate by Type (2014-2019)
Table United States Virus Like Particles Sales (K Pcs) by Application (2014-2019)
Table United States Virus Like Particles Sales Market Share by Application (2014-2019)
Figure United States Virus Like Particles Sales Market Share by Application (2014-2019)
Figure United States Virus Like Particles Sales Market Share by Application in 2018
Table United States Virus Like Particles Sales Growth Rate by Application (2014-2019)
Figure United States Virus Like Particles Sales Growth Rate by Application (2014-2019)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Virus Like Particles Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Figure GlaxoSmithKline Virus Like Particles Sales Growth Rate (2014-2019)
Figure GlaxoSmithKline Virus Like Particles Sales Market Share in United States (2014-2019)
Figure GlaxoSmithKline Virus Like Particles Revenue Market Share in United States (2014-2019)
Table Merck Basic Information List
Table Merck Virus Like Particles Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Figure Merck Virus Like Particles Sales Growth Rate (2014-2019)
Figure Merck Virus Like Particles Sales Market Share in United States (2014-2019)
Figure Merck Virus Like Particles Revenue Market Share in United States (2014-2019)
Table Novavax Basic Information List
Table Novavax Virus Like Particles Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Figure Novavax Virus Like Particles Sales Growth Rate (2014-2019)
Figure Novavax Virus Like Particles Sales Market Share in United States (2014-2019)
Figure Novavax Virus Like Particles Revenue Market Share in United States (2014-2019)
Table Takeda Basic Information List
Table Takeda Virus Like Particles Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Figure Takeda Virus Like Particles Sales Growth Rate (2014-2019)
Figure Takeda Virus Like Particles Sales Market Share in United States (2014-2019)
Figure Takeda Virus Like Particles Revenue Market Share in United States (2014-2019)
Table Medicago Basic Information List
Table Medicago Virus Like Particles Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Figure Medicago Virus Like Particles Sales Growth Rate (2014-2019)
Figure Medicago Virus Like Particles Sales Market Share in United States (2014-2019)
Figure Medicago Virus Like Particles Revenue Market Share in United States (2014-2019)
Table MedImmune Basic Information List
Table MedImmune Virus Like Particles Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Figure MedImmune Virus Like Particles Sales Growth Rate (2014-2019)
Figure MedImmune Virus Like Particles Sales Market Share in United States (2014-2019)
Figure MedImmune Virus Like Particles Revenue Market Share in United States (2014-2019)
Table TechnoVax Basic Information List
Table TechnoVax Virus Like Particles Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Figure TechnoVax Virus Like Particles Sales Growth Rate (2014-2019)
Figure TechnoVax Virus Like Particles Sales Market Share in United States (2014-2019)
Figure TechnoVax Virus Like Particles Revenue Market Share in United States (2014-2019)
Table Agilvax Basic Information List
Table Agilvax Virus Like Particles Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Figure Agilvax Virus Like Particles Sales Growth Rate (2014-2019)
Figure Agilvax Virus Like Particles Sales Market Share in United States (2014-2019)
Figure Agilvax Virus Like Particles Revenue Market Share in United States (2014-2019)
Table Allergy Therapeutics Basic Information List
Table Allergy Therapeutics Virus Like Particles Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Figure Allergy Therapeutics Virus Like Particles Sales Growth Rate (2014-2019)
Figure Allergy Therapeutics Virus Like Particles Sales Market Share in United States (2014-2019)
Figure Allergy Therapeutics Virus Like Particles Revenue Market Share in United States (2014-2019)
Table Serum Institute of India Basic Information List
Table Serum Institute of India Virus Like Particles Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Figure Serum Institute of India Virus Like Particles Sales Growth Rate (2014-2019)
Figure Serum Institute of India Virus Like Particles Sales Market Share in United States (2014-2019)
Figure Serum Institute of India Virus Like Particles Revenue Market Share in United States (2014-2019)
Table GeoVax Labs Basic Information List
Table Cytos Biotechnology Basic Information List
Table ANGANY Genetics Basic Information List
Table CPL Biologicals Basic Information List
Table Xiamen Innovax Biotech Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Virus Like Particles
Figure Manufacturing Process Analysis of Virus Like Particles
Figure Virus Like Particles Industrial Chain Analysis
Table Raw Materials Sources of Virus Like Particles Major Players/Suppliers in 2018
Table Major Buyers of Virus Like Particles
Table Distributors/Traders List
Figure United States Virus Like Particles Sales Volume (K Pcs) and Growth Rate Forecast (2019-2024)
Figure United States Virus Like Particles Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Figure United States Virus Like Particles Price (USD/Pcs) Trend Forecast (2019-2024)
Table United States Virus Like Particles Sales Volume (K Pcs) Forecast by Type (2019-2024)
Figure United States Virus Like Particles Sales Volume (K Pcs) Forecast by Type (2019-2024)
Figure United States Virus Like Particles Sales Volume (K Pcs) Forecast by Type in 2024
Table United States Virus Like Particles Sales Volume (K Pcs) Forecast by Application (2019-2024)
Figure United States Virus Like Particles Sales Volume (K Pcs) Forecast by Application (2019-2024)
Figure United States Virus Like Particles Sales Volume (K Pcs) Forecast by Application in 2024
Table United States Virus Like Particles Sales Volume (K Pcs) Forecast by Region (2019-2024)
Table United States Virus Like Particles Sales Volume Share Forecast by Region (2019-2024)
Figure United States Virus Like Particles Sales Volume Share Forecast by Region (2019-2024)
Figure United States Virus Like Particles Sales Volume Share Forecast by Region in 2024
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources